1. 11P Association of VISTA-expressing CD66b-positive neutrophils, with response and survival benefit from pembrolizumab in advanced malignant pleural mesothelioma. (December 2022) Authors: Homicsko, K.; Zygoura, P.; Tissot, S.; Norkin, M.; Popat, S.; Curioni-Fontecedro, A.; O'Brien, M.E.R.; Pope, T.; Shah, R.; Kammler, R.; Finn, S.P.; Coukos, G.; Dafni, U.; Peters, S.; Stahel, R.A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries. (December 2022) Authors: Cortellini, A.; Dettorre, G.; Dafni, U.; Aguilar Company, J.; Castelo-Branco, L.; Lambertini, M.; Gennatas, S.; Rogado, J.; Vinal Lozano, D.; Harrington, K.J.; Tsourti, Z.; Michielin, O.A.; Pommeret, F.; Brunet Vidal, J.M.; Tabernero, J.; Pentheroudakis, G.; Gennari, A.; Peters, S.; Romano, E.; P... Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3001 Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project. (September 2015) Authors: Kerr, K.; Dafni, U.; Schulze, K.; Thunnissen, E.; Bubendorf, L.; Hager, H.; Gately, K.; Biernat, W.; Vliegen, L.; Hernandez Losa, J.; Marchetti, A.; Cheney, R.; Warth, A.; Speel, E.J.; Blackhall, F.; Molina, M.A.; Shames, D.S.; Peters, S.; Stahel, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3BA A phase II trial of erlotinib (E) and bevacizumab (B) in patients with advanced non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations with and without T790M mutation. The Spanish Lung Cancer Group (SLCG) and the European Thoracic Oncology Platform (ETOP) BELIEF trial. (September 2015) Authors: Stahel, R.A.; Dafni, U.; Gautschi, O.; Felip, E.; Curioni-Fontecedro, A.; Peters, S.; Massutí, B.; Cardenal, F.; Aix, S.P.; Früh, M.; Pless, M.; Popat, S.; Kotsakis, A.; Cuffe, S.; Bidoli, P.; Favaretto, A.; Carcereny, E.; Sanchez Ronco, M.; Molina, M.A.; Rosell, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 5P Tumor microenvironment cellular crosstalk predicts response to adoptive TIL therapy in melanoma patients. (December 2022) Authors: Dangaj, D.; Barras, D.; Ghisoni, E.; Chiffelle, J.; Orcurto, A.; Dagher, J.; Fahr, N.; Dafni, U.; Sempoux, C.; Michielin, O.A.; Trueb, L.; Harari, A.; Coukos, G. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis. (January 2021) Authors: Dafni, U.; Martín-Lluesma, S.; Balint, K.; Tsourti, Z.; Vervita, K.; Chenal, J.; Coukos, G.; Zaman, K.; Sarivalasis, A.; Kandalaft, L.E. Journal: European journal of cancer Issue: Volume 142(2021) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period. Issue 5 (May 2022) Authors: Lazor-Blanchet, C.; Zygoura, P.; Dafni, U.; Lamoth, F.; Tsourti, Z.; Lobritz, M.A.; Regina, J.; Grandbastien, B.; Fenwick, C.; Pantaleo, G.; Calandra, T.; Meylan, S. Journal: Journal of infection Issue: Volume 84:Issue 5(2022) Page Start: 722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial. (July 2019) Authors: Peters, S.; Felip, E.; Dafni, U.; Belka, C.; Guckenberger, M.; Irigoyen, A.; Nadal, E.; Becker, A.; Vees, H.; Pless, M.; Martinez-Marti, A.; Tufman, A.; Lambrecht, M.; Andratschke, N.; Piguet, A.C.; Kassapian, M.; Roschitzki-Voser, H.; Rabaglio-Poretti, M.; Stahel, R.A.; Vansteenkiste, J. Journal: Lung cancer Issue: Volume 133(2019) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug. (August 2020) Authors: Stahel, R.A.; Curioni-Fontecedro, A.; Rohrmann, S.; Dafni, U.; Sandner, U.; Opitz, I.; Andratschke, N.; Franzen, D.; Dimopoulou, G.; Matthes, K.L.; Kohler, M.; Guckenberger, M.; Weder, W. Journal: Lung cancer Issue: Volume 146(2020) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗